Neurona Therapeutics

OverviewSuggest Edit

Neurona Therapeutics is a biotechnology company that focuses on the discovery of regenerative cell-based therapeutics to treat intractable neurological diseases. It aims to generate therapeutic compositions of a specific type of nerve cell for targeted delivery into the injured nervous system.

TypePrivate
Founded2008
HQSouth San Francisco, CA, US
Websiteneuronatherapeutics.com

Latest Updates

Employees (est.) (Jul 2021)54
Cybersecurity ratingAMore

Key People/Management at Neurona Therapeutics

Cory R. Nicholas

Cory R. Nicholas

Co-Founder and Chief Executive Officer
Arnold Kriegstein

Arnold Kriegstein

Co-Founder, Board Director and Scientific Advisor
John Rubenstein

John Rubenstein

Co-Founder and Scientific Advisor
Catherine Priest

Catherine Priest

Vice President of Preclinical Development
Gautam Banik

Gautam Banik

Vice President of Manufacturing and Process Sciences
Paurene Duramad

Paurene Duramad

Senior Director of Regulatory Affairs
Show more

Neurona Therapeutics Office Locations

Neurona Therapeutics has an office in South San Francisco
South San Francisco, CA, US (HQ)
170 Harbor Way
Show all (1)

Neurona Therapeutics Financials and Metrics

Summary Metrics

Founding Date

2008

Neurona Therapeutics total Funding

$57.7 m

Neurona Therapeutics latest funding size

$15 m

Time since last funding

2 years ago

Neurona Therapeutics investors

Neurona Therapeutics's latest funding round in November 2019 was reported to be $15 m. In total, Neurona Therapeutics has raised $57.7 m
Show all financial metrics

Neurona Therapeutics Cybersecurity Score

Cybersecurity ratingPremium dataset

A

94/100

SecurityScorecard logo

Neurona Therapeutics Online and Social Media Presence

Embed Graph

Neurona Therapeutics News and Updates

Neurona Therapeutics Presents Clinical Development Plan for Lead Cell Therapy Program at the 16th Conference on Antiepileptic Drug and Device Trials (AEDD TRIALS XVI)

Supporting data in preclinical model of drug-resistant epilepsy demonstrate seizure-freedom in 70% of the NRTX-1001 cell therapy treatment group versus 5% in the control group

Neurona Therapeutics Presents Preclinical Data from Lead Cell Therapy Program, Demonstrating Significant Seizure Suppression in Model of Focal Epilepsy

Data presented at American Academy of Neuroscience (AAN) Annual Meeting Data presented at American Academy of Neuroscience (AAN) Annual Meeting

Neurona Therapeutics Frequently Asked Questions

  • When was Neurona Therapeutics founded?

    Neurona Therapeutics was founded in 2008.

  • Who are Neurona Therapeutics key executives?

    Neurona Therapeutics's key executives are Cory R. Nicholas, Arnold Kriegstein and John Rubenstein.

  • How many employees does Neurona Therapeutics have?

    Neurona Therapeutics has 54 employees.

  • Who are Neurona Therapeutics competitors?

    Competitors of Neurona Therapeutics include Apoptrol, Beacon Discovery and ADMEcell.

  • Where is Neurona Therapeutics headquarters?

    Neurona Therapeutics headquarters is located at 170 Harbor Way, South San Francisco.

  • Where are Neurona Therapeutics offices?

    Neurona Therapeutics has an office in South San Francisco.

  • How many offices does Neurona Therapeutics have?

    Neurona Therapeutics has 1 office.